Language And Country
MENU - CONTACT
- Contact your adviser by phone or by secure mail, or to make an appointment on our premises,
- Use our e-banking services or our mobile banking application available 24/7, to check your accounts, make payments, check fund performances and read the latest news from Banque de Luxembourg.
MENU - Mon Compte
Please note that a number of fraudulent e-mails are currently circulating, seeking to recover your personal and banking data.
We remind you that Banque de Luxembourg and LuxTrust will never contact you directly via your personal email address, by SMS or by telephone asking you to log in to your secure site and/or to provide confidential information linked to your accounts and bank cards.
Détail d'un fonds
BL Fund Selection 0-50
Flexible fund of funds
Data as of 20/01/2021
Average annual performance since launch 3,20 %
Performance as at 20/01/2021
|Since 01/01/2021||1,54 %|
|Over the last 12 months||9,41 %|
|Over 3 years||10,04 %|
|Since launch||44,27 %|
|Absolute Return||38,70 %|
|Hedged Equities||6,82 %|
|Breakdown by currency|
|Bakersteel Global Precious Metals - I USD CAP||5,52 %|
|Memnon European - I2 Euro CAP||5,45 %|
|Schroder GAIA Egerton Equity - C CAP||5,27 %|
|Pareto Nordic Corporate Bond - B CAP||4,48 %|
|Franklin Templeton Alternative K2 Electron Global -EB PF Acc EUR H2 CAP||4,08 %|
Investment objective and policyThe aim of this fund is long-term capital appreciation via a diversified portfolio of assets while targeting lower volatility than the equity markets. This flexible fund of funds has no geographical, sector or monetary restriction and invests mainly in UCITS and other UCIs. The proportion of investments in the various asset classes will depend on market circumstances. The maximum equity weighting permitted is 50%.
Management report - 4th Quarter 2020The health situation was still difficult at the end of the year, forcing many countries to partially shut down their economies again. The announcement of very promising results from Pfizer (followed by Moderna) on a Covid-19 vaccine with efficacy rates of over 90% spurred the markets in the fourth quarter. Although the vaccines will not be available on a large scale before the Spring, they are already allowing the markets to see a clearer way out of the health crisis at last and envisage a gradual return to normal in the second half of 2021. In this context, the equity weighting was increased from 29.7% to 45.7%. In the last few months, the markets were also buoyed by the results of the US presidential election. Joe Biden's victory offers the prospect of the trade war easing, with China and with other partners around the world. After months of bitter discussions, an agreement was finally reached between the United Kingdom and the European Union in the closing days of 2020. This tide of optimism led to strong gains on the equity markets. The MSCI World index added 9.4% (in EUR), driven by emerging markets (+14.7% in EUR) and European markets (+10.9%), which have a greater proportion of cyclical stocks, the quarter's main beneficiaries. The US markets gained 7.5% (in EUR). BL Fund Selection 0-50 benefited from this favourable environment for risky assets to grow by 5.4%. Over the year 2020 as a whole, BL Fund Selection 0-50 gained 8.6%. In the fourth quarter, the fund benefited from the good performance of all its components and from the decision to take on more risk from the end of October. Gold-mining funds were alone in posting significantly negative performance overall for the quarter (-4.2%) as the price of gold consolidated after a good start to the year. All segments of the portfolio delivered some pleasing results. Kirao Smallcaps (+19.7%) and Nordea Nordic Equity Small Cap (+17.4%) headed the equity funds, while Mirabaud Sustainable Convertible Global (+17%) and Lazard Global Convertibles Recovery (+11%) were top of the bond funds. In the absolute return segments, Franklin K2 Electron Global Equity (+29.5%), BDL Rempart Europe (+19.2%) and Liontrust European Strategic Equity (+15.2%) stood out among the directional funds and Exane Overdrive (+7.9%) and Boussard & Gavaudan Absolute Return (+6.7%) among the decorrelated funds. As the equity weighting was increased during the quarter, the more cyclical funds and small cap funds were strengthened. At the end of December, the fund’s equity weighting of around 46% (5.8% in gold-mining) was high compared to its historic position, and reflects a degree of optimism in the capacity of vaccine distribution to protect the financial markets against the risk of a major correction.
|Net Asset Value|
|Calculated||Every business day|
|NAV class B capitalisation shares (20/01/2021)||144,27 EUR|
|CODES||ISIN capitalisation code : LU0430649086 |
WKN capitalisation code : A0RNSS
|Net assets (million)||420,61 EUR|
Détail fonds - disclaimer
Before making any decision to subscribe, customers must ensure they have understood the product, having measured the risks associated with it and consulted their own advisers on the appropriateness of the product for their particular financial situation, taking into account legal, tax and accounting aspects. This fact sheet has been drawn up for information purposes and shall in no event be considered a solicitation to buy or an offer to sell securities or other financial instruments. Information provided to the interested party does not constitute legal or fiscal advice and the Bank shall not be held liable for such information. The securities referred to in this document may cause the investor to incur significant risk and may not be appropriate for all investors. Such risks include market risks, high volatility, credit risk, liquidity risk and interest-rate risk. There is no guarantee that the securities described in this document will achieve their investment objectives. Past performance is no indication of future returns. The Bank shall not be held liable for the future performance of these securities. Potential investors must ensure that they understand the risks of investing in such products and should only take an investment decision after giving careful consideration, together with their professional advisers, to the appropriateness of this investment to their specific financial situation, particularly with regard to legal, tax and accounting aspects. We have made every effort to verify that the information presented in this document is correct, in particular the estimated values, opinions and other estimates. Nevertheless, no guarantee can be given as to the validity, timeliness, completeness, correctness or accuracy of the information, which is provided for guidance only. Information may be subject to change without prior notice.